RL
Therapeutic Areas
Cetya Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CT-101 | Sickle Cell Disease | Pre-clinical |
| HDACi Platform (unspecified candidates) | Liquid Tumors (Leukemias, Lymphomas) | Research |
| Drug | Indication | Phase |
|---|---|---|
| CT-101 | Sickle Cell Disease | Pre-clinical |
| HDACi Platform (unspecified candidates) | Liquid Tumors (Leukemias, Lymphomas) | Research |